Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069719 · ClinicalTrials.gov registry record · Phase 2
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
A Phase 2 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00069719: Completed Phase 2 study, sponsored by Alcon Research.
NCT00069719 is a Phase 2 study that has completed, run by Alcon Research. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00069719, a Phase 2 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
Interventions
- DRUG Glaucoma therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-02 |
| Est. Completion | 2003-08 |
| Phase | Phase 2 |
What the finished NCT00069719 record still lists
NCT00069719 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Glaucoma therapy is the first listed.
NCT00069719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00069719 about?
NCT00069719 is a clinical study titled "Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients". To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
What is the current status of trial NCT00069719?
This trial is currently completed. It is a Phase 2 study. The study started on 1999-02. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00069719?
The interventions under investigation include: Glaucoma therapy (DRUG).
Who is sponsoring clinical trial NCT00069719?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia